Glycosaminoglycan-Replenishment Therapy: Rationale For Use and Current Evidence

Summary of Presentations from the IBSA Institut Biochimique SA Symposium, held at the 29th Annual EAU Congress, Stockholm, Sweden, on 12th April 2014

Chairperson: Mauro Cervigni,1 Phillip E. Van Kerrebroeck2
Speakers: Paulo Dinis Oliveira,3 Rosanna Tarricone,4 Salvador Arlandis Guzman5

1. Polyclinic Gemelli, Catholic University, Rome, Italy
2. MUMC, Maastricht, the Netherlands
3. Hospital São João, Faculty of Medicine of Porto, Porto, Portugal
4. CERGAS Bocconi University, Milan, Italy
5. Hospital Universitario y Politécnico La Fe, Valencia, Spain

Disclosure: The authors are invited speakers for IBSA Institut Biochimique SA and declare no conflicts of interest.
Acknowledgements: Writing assistance provided by Dr Tabasum Mughal.
Support: The publication of this article was funded by IBSA Institut Biochimique SA. The views and opinions expressed are those of the authors and not necessarily of IBSA Institut Biochimique SA.
Citation: EMJ Urol. 2014;1:41-47.

Download (PDF, 279KB)

Comments are closed.